The African swine fever virus protein p12, involved in virus attachment to the host cell, has an apparent molecular mass of 17 kDa in sodium dodecyl sulfate-polyacrylamide gel electrophoresis under nonreducing conditions. We have also identified 
baculovirus-expressed protein p12 to Vero cells was specifically blocked by virus particles. In addition, the recombinant protein purified by immunoaffinity chromatography blocked the specific binding of virus particles to susceptible cells and prevented infection, demonstrating that the p12 protein mediates the attachment of virions to specific receptors and indicating that blocking the p12-mediated interaction between African swine fever vims and receptors in Vero cells can inhibit infection. However, although antibodies specific for protein p12 are induced in natural infections and in animals inoculated with inactivated virus or recombinant protein p12, these antisera did not inhibit virus binding to the host cell or neutralize virus infectivity.
African swine fever virus (ASFV) is an enveloped icosahedral deoxyvirus that causes an important disease in domestic pigs (for reviews, see references 15, 18, 40, and 41) . A peculiar aspect of the ASFV infection is the absence of neutralizing antibodies in recovered or chronically infected pigs or in ASFV-resistant animal species inoculated with the virus, a fact that has prevented the use of conventional vaccines (16) . The complexity of the virus particle, which contains more than 30 proteins in the Vero cell-adapted BA71 strain (BA71V) (11) , increases the difficulties of identifying virus structural proteins that may constitute targets for neutralizing antibodies.
The attachment of virus particles of the BA71V strain to Vero cells and swine macrophages is mediated by specific receptors (2, 3) . The structural protein p12, localized in the virus periphery, has been involved in mediating the attachment of ASFV particles to specific receptors in Vero cells (12, 13) . The protein immunoprecipitated from purified virus particles shows an apparent molecular mass of 17 kDa in sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) in the absence of reducing agents. After subsequent reduction and alkylation, this polypeptide shows molecular masses of 12 and 10 kDa, respectively, indicating that disulfide bonds are involved in the oligomerization of the polypeptide (1, 13) . Protein p12 is encoded by open reading frame (ORF) 061R, which is predicted to code for a 61-amino-acid polypeptide chain, with a hydrophobic, putative transmembrane domain in the central part and a cysteine-rich domain in the carboxy-terminal region, which may account for the oligomerization of the polypeptide through disulfide bonds (1) . No posttranslational modification of the polypeptide, such as glycosylation, phosphorylation, or fatty acid acylation, has been found. The sequence of this gene is highly conserved in natural isolates, suggesting an essential role for protein p12 during the virus replication cycle (5) . The expression of ORF 061R in Escherichia coli and in vitro translation systems gave rise to a 12-kDa polypeptide that did not bind to Vero cells (1) , raising the question of whether oligomerization of the polypeptide, posttranslational modifications not yet identified, or a correct folding of the protein, which may not take place in the expression systems previously used, is required for binding to the host receptor. Finding an expression system able to produce large amounts of protein in its natural conformation was necessary to define the role of protein p12 in ASFV infection.
In the present report, we have identified and localized the 12-and 10-kDa forms of the p12 protein in ASFV-infected Vero cells. This protein has been expressed in insect cells infected with a recombinant baculovirus, giving rise to a 17-kDa protein that interacts specifically with sensitive Vero cells. The baculovirus-expressed protein has been purified by immunoaffinity chromatography and was able to block the binding of virus particles to Vero cells and prevent infection. The presence of specific antibodies against protein p12 in infected pigs and in animals inoculated with inactivated virus or recombinant protein p12 has been studied.
MATERIALS AND METHODS
Cells and viruses. Vero and L cells were obtained from the American Type Culture Collection and cultured in Dulbecco's modified Eagle (DME) medium supplemented with 10% calf serum. The Vero cell-adapted ASFV strain BA71V (19) was purified from supernatants of infected cultures by the Percoll sedimentation method (11) .
Autographa californica nuclear polyhedrosis virus (AcNPV) and Spodoptera frugiperda 9 (Sf) cells were obtained from D. H. L. Bishop (Institute of Virology and Environmental Microbiology, Oxford, United Kingdom) and were cultured in TC100 medium (GIBCO-BRL) supplemented with 10% fetal calf serum (7) .
Construction of the expression plasmid pAc061R. A 480-bp fragment containing ORF 061R was excised from plasmid pETO61R (1) after digestion with NdeI and BamHI, and the ends were filled in with Klenow fragments. This fragment was cloned into the Klenow fragment-repaired BamHI site of pAcYMi (26) , and the resultant plasmid was named pAcO61R. The presence and orientation of inserts were determined by restriction enzyme analysis, and the 5' cloning junction was confirmed by DNA sequencing analysis. DNA manipulations were performed by standard procedures (33) .
Transfection and selection of recombinant viruses. Sf cells were cotransfected with purified AcNPV DNA, prepared as described previously (36) , and pAcO61R with lipofectin (GIBCO-BRL), according to the instructions provided by the manufacturer. Culture supernatants were harvested 2 and 3 days posttransfection and used for plaque assays. Polyhedrin-negative plaques were isolated and purified by three consecutive plaque assays, and the recombinant virus containing ORF 061R was named Acpl2. The insertion of the gene into the virus genome was confirmed by Southern blot hybridization of a 32P-labeled specific probe on viral DNA, isolated by the Hirt method (22) from infected Sf cells and digested with HindIII.
Antibodies. Rabbits or miniature pigs (32) were immunized against different antigens, and antisera were prepared by standard procedures (20) . Cultures of E. coli BL21(DE3) transformed with pETO61R and induced for 90 min with 1 mM isopropyl-3-D-thiogalactopyranoside or Sf cells infected with Acpl2 for 3 days were lysed by sonication in phosphate-buffered saline (PBS) and used as immunogens. A peptide of 60 residues (pO60) corresponding to the predicted amino acid sequence of protein p12, excluding the initiator methionine, and the peptide pNCT comprising the aminoand carboxy-terminal regions, which excluded the central hydrophobic sequence and the initiator methionine (AL DGSSGGGSNVETMPRQQKKCSKAEECTCNNGSCS LKTS) (14) , were also used to raise specific antisera. The amounts of protein inoculated were 1 mg for E. coli and Sf cell extracts and 150 ,g for peptides. The monoclonal antibody 24BB7, specific for protein p12, has been described elsewhere (13) . Monoclonal antibodies 19BA2 and 19EH10 against the major structural protein p72 and the membrane protein p24, respectively, were used as controls in immunofluorescence (34 (11) . The radioactive samples were dissociated in 10 mM Tris-HCl (pH 7.5)-150 mM NaCl-1% sodium deoxycholate-1% Nonidet P-40-0.1% SDS-1 mM phenylmethylsulfonyl fluoride and immunoprecipitated by the indicated antisera or monoclonal antibodies, and protein A-Sepharose (20) . For the electrophoretic analysis, whole extracts or immune complexes were dissociated in sample buffer containing 40 mM Tris-HCl (pH 6.3), 2.3% SDS, and 10% glycerol, in the absence or presence of 5% 2-mercaptoethanol. Samples were analyzed by SDS-PAGE in 7 to 20% polyacrylamide gels as described previously (23) . Radioactive bands were detected by autoradiography or fluorography (6) . Protein bands were quantitated by laser scanning densitometry, using preexposed films in the case of the radioactive bands (24 The infectious virus was added after the preincubation period of 4 h at 4°C in the presence of the competitors and incubated for 2 h at 4°C. The monolayer was washed with DME medium, and the infection was continued at 37°C in the presence of the corresponding amount of competitor. In this case, the purified ASFV was UV inactivated as described previously (2). The total virus production (cells and medium) was determined 24 h after infection. Purification of protein p12 expressed in insect cells. Purified 24BB7 immunoglobulin was covalently linked to cyanogen bromide-activated Sepharose 4B to a final concentration of 1.4 mg/ml of gel, following the instructions provided by the manufacturer (Pharmacia). Acpl2-infected Sf cells were dissociated with 1% OG for 1 h at 4°C and centrifuged in a Beckman Airfuge at 130,000 x g for 10 min. The solubilized proteins were applied to the column, and after extensive washings with PBS, the material bound was eluted with 50 mM diethylamine, pH 11. The eluted material was neutralized immediately with glycine saturated in water, concentrated, and dialyzed against PBS or DME-H medium at 4°C. The affinity column was estimated to bind 150 to 200 pug of protein p12 per ml of gel. The protein concentration was determined with the BCA kit, according to the instructions provided by the manufacturer (Pierce Chemical Co.).
Inhibition of virus binding to cells by antisera and virus neutralization test. Virus binding in the presence of different antisera was analyzed by incubating 1.5 x 105 cpm of "I-labeled purified ASFV with 10 or 20 ,ul of antiserum in 100 p.1 of DME-H medium. After 12 h at 37°C, the samples were added to Vero cell monolayers and incubated at 4°C for 4 h, and the radioactive material bound to the cells was determined. The neutralization capacities of the antisera were tested by a plaque reduction assay of extracellular infectious BA71V as described before (13) . Briefly, the virus was incubated overnight at 4 or 37°C with a 1/4 dilution of the antisera. After an incubation of 1 h at 37°C in the absence or presence of rabbit complement, virus infectivity was assayed in monolayers of Vero cells.
RESULTS
Reactivities of antisera specific for protein p12. To raise specific antisera, rabbits were immunized with E. coli extracts containing protein p12 (1) or insect cells infected with a recombinant baculovirus expressing the protein (described below). Synthetic peptides corresponding to the complete predicted amino acid sequence of protein p12 (pO60), and to chimeric amino-and carboxy-terminal hydrophilic regions (pCNT), which lacked the hydrophobic core (14) , were also used as immunogens. The specific reactivities of the antisera were tested by immunoprecipitation of 35S-labeled infected Vero cells and purified virus particles. Figure 1A shows that the antisera recognized different forms of the protein in infected cells. Whereas most of the antisera recognized the 17-kDa protein, the one raised against the peptide pO60 detected only the 12-kDa form (Fig. 1A , lane e), even after longer exposures of the fluorograph. The antiserum against p12 expressed in E. coli specifically recognized the 12-kDa polypeptide in addition to the 17-kDa one (Fig. 1A, lane c) , and the antiserum against the peptide pNCT also clearly immunoprecipitated the 10-kDa polypeptide over the background levels (Fig. 1A, lane f) . As described before (1, 13), the monoclonal antibody 24BB7 immunoprecipitated the 17-kDa form of the protein (Fig. 1A, lane b) . Interestingly, the immunoprecipitation of purified virions detected exclusively the 17-kDa protein (Fig. 1B) , indicating that this is the only form present in extracellular virions. The inability of the antiserum against the protein expressed in E. coli to immunoprecipitate the protein from virions (Fig. 1B, lane c) , while it recognizes the protein in infected-cell extracts, might reflect a lower antigenicity or accessibility of the protein present in the virus particle to these antibodies. Antisera from pigs immunized with p12 produced in insect cells or with peptide pNCT immunoprecipitated the 17-kDa polypeptide from both virus-infected Vero cells and purified virions (data not shown).
Detection of protein p12 in ASFV-infected Vero cells by immunofluorescence. Immunofluorescence experiments using the p12-specific antisera described above, with differential reactivities for the 17-, 12-, and 10-kDa forms, were performed to identify the subcellular localization of the protein. The monoclonal antibody 24BB7, which recognizes exclusively the 17-kDa polypeptide, identified the protein at 16 h postinfection in discrete perinuclear cytoplasmic areas (Fig. 2) . This region corresponded to viral factories where virus morphogenesis occurs, and accordingly, they were also labeled with monoclonal antibody 19BA2 specific for the major structural protein p72 (34; data not shown). From 20 h postinfection, a speckled cytoplasmic pattern was observed, with the protein concentrated in specific areas of the cell periphery, especially where cell-cell contact occurs, that might correspond to specialized regions from which the virus is released into the medium. An identical immunofluorescence pattern was obtained with the antiserum against the E. coli-expressed protein (Fig. 2) and the other antisera, described above, that recognized the 17-kDa form and in some cases other forms (data not shown). However, the antiserum against the peptide pO60 that recognized only the 12-kDa form labeled exclusively viral factories both at 16 and 20 h postinfection (Fig. 2) , indicating that only the mature 17-kDa protein is transported to the cell surface, presumably as part of the virus particle. No immunofluorescence was detected with the different antisera or monoclonal antibody 24BB7 in the plasma membrane under nonpermeable conditions for the antibodies, while as a control an intense signal was obtained with the monoclonal antibody 19EH10 against the membrane protein p24 (34; data not shown).
Structural and biological properties of protein p12 produced in insect cells. To produce large amounts of protein p12 in an eukaryotic system, a recombinant AcNPV, named Acpl2, was constructed which contained ORF 061R inserted into the polyhedrin locus and transcribed under the control of the strong polyhedrin promoter. To identify the gene product, insect cells infected with the recombinant baculovirus were labeled with [35S]methionine at different times of infection and the cell extracts were analyzed by SDS-PAGE. Figure  3A shows that a polypeptide of 12 kDa under reducing conditions, and not polyhedrin, was synthesized in Acpl2-infected insect cells. A densitometric analysis revealed that 60% of the total radioactivity was incorporated into protein p12 in a 24-to 72-h postinfection pulse, reflecting a high level of expression. A polypeptide of 17 kDa under nonreducing conditions was also detected and constituted about 75% of total protein p12 by densitometry, although we have found that this percentage varies slightly among experiments. The immunoprecipitation by monoclonal antibody 24BB7 confirmed the identity of the protein and corroborated the higher affinity of the monoclonal antibody for the 17-kDa form, since the 12-kDa form present in Acpl2-infected cells was not immunoprecipitated (Fig. 3A, NON REDUCING) . The finding of a 12-kDa protein when the immunoprecipitated proteins were analyzed in the presence of reducing agents showed that the 17-kDa band corresponded to an oligomer of p12 (Fig. 3A, REDUCING) . (C and D), or rabbit antisera against protein p12 expressed in E. coli (E and F) or peptide pO60 (G and H).
To determine the stability of the protein, pulse-chase experiments were performed in insect cells infected with Acpl2, and the cell extracts were immunoprecipitated by monoclonal antibody 24BB7 and by antisera against protein p12 expressed in E. coli or against peptide pNCT. Interestingly, while this monoclonal antibody recognized exclusively the 17-kDa polypeptide in Acpl2-infected insect cells when analyzed under nonreducing conditions, the antisera used detected 10-kDa forms, 15-to 16-kDa forms, and a ladder of higher-molecular-mass species, in which seven forms could be identified with a size difference of 6 to 8 kDa among them (Fig. 3B) . The amount of 17-kDa protein increased clearly during the chase period, while those of 10 kDa, 15 to decreased. These results suggested that the mature product is the 17-kDa protein. When the electrophoretic analysis was performed in the presence of 2-mercaptoethanol, two bands of 12 and 10 kDa were detected, which illustrated the oligomeric nature of the bands containing >12-kDa protein (data not shown).
To test the binding properties of the protein, OG extracts of baculovirus-infected Sf cells were prepared and used in binding experiments to Vero and L cells. Figure 4 shows that no binding of any 35S-labeled protein from AcNPV-infected cells was detected, while specific binding of protein p12 to Vero cells but not to L cells was observed with Acpl2-infected cells. The specificity of the interaction was also shown by the fact that the binding of the recombinant protein p12 to Vero cells was blocked by ASFV particles and not by bovine serum albumin. This result demonstrated that the protein produced in the baculovirus system possessed the biological properties of the protein naturally found in ASFV particles.
Purification of protein p12 expressed in the baculovirus system. The protein produced in the baculovirus system was purified from OG extracts of Sf cells infected with Acpl2 by immunoaffinity chromatography in Sepharose 4B columns with covalently bound monoclonal antibody 24BB7, as described in Materials and Methods. Figure 5 shows the different steps in the purification procedure. Protein p12 constituted the major band selected in the immunoaffinity column and had a molecular mass of 17 kDa in the absence of reducing agents. The apparent molecular mass was reduced to 12 kDa in the presence of 2-mercaptoethanol (data not shown). The purified protein retained the biological properties, since it was able to interact with Vero cells, and this binding was blocked by unlabeled virus particles (data not shown).
Competition of binding and infectivity by purified protein p12. The capacity of the purified protein p12 produced in insect cells to block the binding of "NI-labeled protein p12 released by OG from virus particles or entire virions was tested. Figure 6A shows that the binding of labeled viral protein p12 to Vero cells, which was analyzed by SDS-PAGE, was blocked in a dose-dependent manner by purified recombinant protein, and not by bovine serum albumin, to a level similar to that obtained when virus particles were used as competitor. The binding of "2I-labeled ASFV to Vero cells was also blocked specifically by purified protein p12 to levels comparable to those obtained with an excess of purified virus particles (Fig. 6B) . The inability of the purified protein p12 to totally block the virus binding can be explained by the existence of nonsaturable interactions with Vero cells that cannot be blocked by an excess purified virus (2) .
The capacity of purified protein p12 to inhibit the specific binding of ASFV to the host cell demonstrated that both protein p12 and virus particles recognize the same receptor in Vero cells. In accordance with this, the production of ASFV in Vero cells was dramatically reduced, in a dosedependent manner, in the presence of purified protein p12 ( Table 1 inhibited the binding of labeled purified virus particles to Vero cells in experiments performed as described in Materials and Methods (data not shown). DISCUSSION pathic effects produced in Vero cells as a result of the ASFV replication were also inhibited when purified protein p12 was present and correlated with the reduction of virus production (data not shown).
Immune responses against protein p12. According to the results obtained in the competition experiments, blocking the interaction of protein p12 with the receptors in the target cell by means of antibodies against this protein might neutralize the virus particles. For this reason, the immune responses against protein p12 were studied. A number of serum or plasma samples obtained from animals infected with ASFV or inoculated with viral proteins or inactivated virus were tested for the presence of antibodies specific for protein p12 by immunoprecipitation. Table 2 shows that 11 of 14 serum and plasma samples tested recognized protein p12 produced in insect cells. However, it was remarkable to find that only one serum sample recognized protein p12 in the virus particle, suggesting a lower antigenicity of the protein present in virions.
On the other hand, the antisera raised in rabbits or pigs against recombinant protein p12 or the peptides described above recognized protein p12 in the virus particles or infected cells (see above). However, these antisera did not neutralize the infectivity in the absence or presence of complement, in neutralization experiments performed by preincubating the virus particles with the antisera at 4 and 37°C (data not shown). Similarly, none of the antisera Protein p12 of ASFV, which is involved in cell attachment, shows an apparent molecular mass of 17 kDa by SDS-PAGE in the absence of reducing agents (13) . Here we show, by means of antisera with different specificities raised against protein p12, that 12-and 10-kDa polypeptides constitute natural forms of the protein found in infected cells, which were previously detected after in vitro reduction and alkylation of the 17-kDa protein immunoprecipitated from virus particles (1, 13) . Interestingly, the mature protein incorporated into virions consists exclusively of the 17 kDa form. This is in agreement with immunofluorescence experiments in which a serum sample that recognized only the 12-kDa form labeled viral factories, where the morphogenesis of the virus takes place, but not the speckled cytoplasmic staining that probably corresponds to virions that are being transported toward the cell surface. The intracellular incorporation in viral factories of a virus protein present in the outer envelope of the virion, together with the absence of protein p12 in the plasma membrane, suggests that incorporation of the external virus envelope may take place intracellularly, as has been shown in other enveloped viruses, such as poxvirus (27) , bunyavirus (29) , coronavirus (37) , and flavivirus (25) . This hypothesis would be in disagreement with the only electron microscopy study on ASFV morphogenesis that shows that the outer envelope is acquired by budding through the plasma membrane (28) . Further studies will be required to define in detail the morphogenesis of ASFV particles. In any case, the immunofluorescence observed with p12-specific antibodies reflects most likely the pathway that virus particles follow before being released from the cells, which seems to take place in specialized regions of the membrane that localize preferentially in areas of cell-cell contact.
We have shown previously that the expression of protein p12 in E. coli and in a cell-free system gives rise to a 12-kDa polypeptide (1) . The failure to detect the 17-kDa form was interpreted as the absence of oligomerization of the polypeptide through disulfide bonds caused by the highly reducing conditions found in the cytoplasm. The synthesis of the 17-kDa form in eukaryotic systems that provide competent membranes for efficient translocation of the polypeptide chain, such as baculovirus and vaccinia virus (4) , is in agreement with this view. In addition, these results also support the topological model proposed for the polypeptide, in which the C-terminal region containing the cysteine residues is translocated through the membrane, and is found in the lumen of the endoplasmic reticulum and later in the extracellular space, where optimal conditions are found for the formation of disulfide bonds and covalent oligomerization of the protein. (31, 42) . If that is the case, alternative mechanisms of 
